Qureight Partners with King Faisal Specialist Hospital and Research Centre for Innovative Lung Transplant Research Pilot

Qureight has announced a partnership with King Faisal Specialist Hospital and Research Centre for Innovative Lung Transplant Research Pilot

12th December 2023

Cambridge, UK, & Riyadh, Saudi Arabia

Qureight launched a research pilot in collaboration with the King Faisal Specialist Hospital and Research Centre, with the aim of enhancing the success rate of lung transplant procedures.

This joint effort involves the analysis of lung scan data obtained from a group of lung transplant patients at the King Faisal Specialist Hospital and Research Centre (KFSH&RC), Saudi Arabia. The analysis will be conducted using Qureight's exclusive AIR8 algorithm, designed to identify connections between airway dimensions and shapes and the probability of organ rejection.

Improving Outcomes for Lung Transplant Patients: 

Patients undergoing lung transplants all face the risk of postoperative organ scarring and fibrosis. If left undetected, these issues can lead to the rejection of the transplanted lungs, putting the patient at risk of organ failure. As such, regular monitoring of organ health is a crucial postoperative requirement.

Currently, the primary method for monitoring the health of transplanted lungs is through regular, invasive, and costly biopsies. In pursuit of a viable, non-invasive alternative to biopsies, pre- and postoperative scans from lung transplant patients at KFSH&RC will be subjected to analysis using Qureight's proprietary AIR8 algorithm.

The results of this analysis are expected to advance medical professionals' understanding of the relationship between a patient's airway volume, size, and shape and the likelihood of their transplanted lungs being rejected.

A more comprehensive understanding of any correlations discovered could pave the way for the replacement of monthly post-transplant biopsies with safer, quicker, and non-invasive lung scans. Such a development would significantly enhance the quality of life for transplant patients and represent a major breakthrough in the field of organ transplant medicine.

Dr. Muhunthan Thillai, CEO and co-founder of Qureight, commented, "This groundbreaking pilot project offers an ideal application for our AIR8 algorithm. The results of the scan data analysis could play a pivotal role in shaping the future of lung transplantation, offering insights that may lead to reduced rates of organ rejection and a significantly improved quality of life for patients. The Qureight team is honored to collaborate with the world-class team at the King Faisal Specialist Hospital and Research Centre to enhance lung transplant outcomes."

Dr. Dieter Broering, Executive Director, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre added, "At KFSH&RC, our unwavering commitment lies in the continuous evolution of solutions and the enhancement of patient care outcomes. The initiation of this pilot research project is driven by our goal to unlock invaluable insights from the lung scan data collected from our transplant patients. Qureight's AIR8 algorithm holds the potential to furnish insights that could significantly advance our understanding of lung physiology, ultimately reducing our dependence on biopsies. We look forward to the implementation of Qureight's algorithm and our close collaboration with their team to elevate the quality of our post-procedure monitoring process.”